questionText: To ask the Secretary of State for Health and Social Care, what assessment he made of the use of dopamine agonists as a first-line treatment for restless legs syndrome (RLS) before the NICE guidance was updated in February 2025; and what steps he is taking
answerText: No assessment has been made. The National Institute for Health and Care Excellence has not developed any guidelines on the diagnosis and/or management of restless leg syndrome (RLS) but has commissioned a Clinical Knowledge Summary (CKS) on the diagnosis ...
heading: Restless Legs Syndrome: Medical Treatments